Literature DB >> 9622306

Occurrence and spontaneous remission of Graves' hyperthyroidism preceded by painless thyroiditis.

Y Nagai1, T Toya, K Fukuoka, N Tanaka, S Yanagi, K Kobayashi.   

Abstract

A 45-year-old woman was referred to our hospital because of discomfort in the cervical region. Laboratory findings revealed thyrotoxicosis with positive TSH receptor antibodies, but acute inflammatory data were absent. After three weeks the thyroid hormone levels spontaneously decreased to hypothyroid levels, and thyroidal radioactive iodine uptake (RAIU) was below normal. A needle-biopsy specimen of the thyroid gland obtained two months later showed diffuse lymphocytic thyroiditis, and she was therefore diagnosed as having had painless thyroiditis. Two months after returning to euthyroidism, a second thyrotoxicosis developed. TSH receptor antibodies remained positive, but RAIU was slightly above normal, indicating Graves' hyperthyroidism. Treatment with antithyroidal drugs was commenced but was soon discontinued due to an allergic reaction. Although only beta-adrenergic antagonist was administered for treating the thyrotoxicosis, thyroid function was gradually normalized in parallel with the reduction in TSH receptor antibody. In this case, painless thyroiditis would be followed by Graves' disease and subsequent spontaneous remission.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9622306     DOI: 10.1507/endocrj.44.881

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  3 in total

1.  Differentiation between Graves' disease and painless thyroiditis by diffusion-weighted imaging, thyroid iodine uptake, thyroid scintigraphy and serum parameters.

Authors:  Zhaowei Meng; Guizhi Zhang; Haoran Sun; Jian Tan; Chunshun Yu; Weijun Tian; Weidong Li; Zhiqiang Yang; Mei Zhu; Qing He; Yujie Zhang; Shugao Han
Journal:  Exp Ther Med       Date:  2015-04-17       Impact factor: 2.447

2.  SARS-CoV-2 vaccine-associated subacute thyroiditis.

Authors:  G Yorulmaz; M Sahin Tekin
Journal:  J Endocrinol Invest       Date:  2022-02-19       Impact factor: 4.256

3.  Antithyroid Drug Treatment in Graves' Disease.

Authors:  Jae Hoon Chung
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.